********************************************************************************
RefSeq-release87.txt       ftp://ftp.ncbi.nlm.nih.gov/refseq/release/release-notes/

		NCBI Reference Sequence (RefSeq) Database

			Release 87
			March 5, 2018

		Distribution Release Notes

Release Size:
   77225 organisms
   1266924789413 nucleotide bases
   40799318419 amino acids
   155118991 records

   Aug 24, 2018
   ftp://ftp.ncbi.nlm.nih.gov/refseq/release/release-notes/RefSeq-release87.txt
   Number of bacterial genomes: 49711
******************************************************************************

ftp://ftp.ncbi.nlm.nih.gov/refseq/release/bacteria/

******************************************************************************
Moduar type I KS based on Maureen's tree (11)

>KSvicenistatin vicen_001_KS_002.seq Expect = e-143  length= 427( 2220- 2647)
DPVVIVGMGCRFPGDVRTPEDLWRLVSNGSDAVTPFPDNRAWDIEGIYDPLPGVSGKTYA
REGGFLHDAAEFDPEFFGISPREALAMDPQQRLLLETSWEAIERAGIDPNSLRGTQTGVF
AGVMQTDYGNGGARLAEDVEGYIANGTLGSIVSGRVSYALGLEGPAVTIDTACSSSLVAM
HWAAHALRQGECSLALAGGVTVMSTPETFVDFSLQRGLAPNGRCKAFSADADGTGWGEGV
GVLVLERLSDARRNGHQVLAVIRGSALNQDGASNGLTAPNGPSQQRVIRQALVSAGLTTS
DVDAVEAHGTGTTLGDPIEAQALLATYGQERDADQPLWLGSVKTNVGHTQAAAGVAGVIK
MVLAMRAGVLPKTLHVTEPSPHVDWSAGAVELLTETRDWPETGRPRRAGVSSFGVSGTNA
HVIVEQAP

>KSmycolactone myloc_001_KS_002.seq Expect = e-136  length= 424( 1817- 2241)
EPVAVVGMACRFPGGVASADQLWDLVIAGRDVVGNFPADRGWDVEGLFDPDPDAVGKTYT
RYGAFLDDAAGFDAGFFGISPREARAMDPQQRLLLEVCWEALETAGIPAHTLAGTSTGVF
VGAWAQSYGATNSDDAEGYAMTGGATSVMSGRIAYTLGLEGPAITVDTACSSSLVAIHLA
CQSLRNNESQLALAGGVTVMSTPAVFTDFSRQRGLAPDGRCKAFAATADGTGWGEGAAVL
VLERLSEARRNNHPVLAIVAGSAINQDGASNGLTAPHGPSQQRVINQALANAGLTHDQVD
AVEAHGTGTTLGDPIEAGALHATYGHHHTPDQPLWLGSIKSNIGHTQAAAGAAGVVKMIQ
AITHATLPATLHVDQPSPHIDWSSGTVRLLTEPIQWPNTDHPRTAAVSSFGISGTNAHLI
LQQPP

>KSgeldanamycin gelda_001_KS_002.seq Expect = e-136  length= 427( 3170- 3597)
EPIAVVAMSCRLPGGVTDPDGLWNLLLEERDGIADFPRDRGWDLEALFDADPDRSGTSYV
LRGGFLEDAAGFDADFFGISPREALAMDPQQRLFLEACWEVFERAGMDPTTVGGGDIGVF
AGVINQDYGVRSGPAPEDLEGYMLTGSATSVASGRVAYVLGLEGPAVTVDTACSSSLVAM
HWAVQALRQGECSMALAGGATVMGRPSAFVEFSRQRGLAPDGLCKAFGAGADGTTFSEGV
GVLLLERLSDARRNGHEVLAVIRGTAVNQDGASNGLTAPNGPSQQRVIRQALANAGLSAT
DIDAVEAHGTGTALGDPIEAQALLATYGQDRPGDEPVWLGSLKSNTGHTLAAAGVSSVIK
MVLAMRHGTLPRSLYADEPTPEVDWSQGAVSLLTEARPWPETSHPRRAGISSFGISGTNA
HLILEQAP

>KSborrelidin borre_002_KS_001.seq Expect = e-145  length= 428(   34-  462)
EPIAIVGMSCRLPGGVNSPGEFWSLLEAGTDAVSEFPRDRGWDVENLYDPDPDAPGRSYV
REGGFLDGAGQFDAAFFGISPREALAMDPQQRLLLECSWEAIERSRIDPKTLHGSRTGVF
AGSNWQDYNTLLLNAEERSQSYLATGASGSVLSGRVSYTLGMEGPAITVNTACSSSLVAV
HLAARSLRAGECDLALAGAVTVMSTPQLPVAFSRQRGLAPDGRSKAFAVSADGMGFGEGV
GVLVLERLSVARRNGHRVLAVVRGSAVNQDGASNGLTAPNGPSQQRVIRAALASAGLGPA
DVDVVEAHGTGTRLGDPIEAQALLATYGRGRDAERPLWLGSVKSNIGHAQAAAGVAGVIK
MVLAMEKGRLPRTLHVDEPSGEVDWDSGAVRLLTEARDWPSEEGRLRRAGVSSFGISGTN
AHVIIEEAP

>KSnystatin nysta_002_KS_001.seq Expect = e-141  length= 422(   42-  464)
EPIAIVGMGCRLPGGVNSPESLWDLVRSGGDAISGFPVDRGWDLETLTGNGDGSSATHEG
GFLYDAAEFDAAFFGISPREATAMDPQQRLLLEVAWEALERAGIAPTALRGSRSGVFVGS
YHWGAPSADAATELHGHALTGTAASVLSGRLAYTLGLEGPAVTVDTACSSSLVALHLAAQ
SLRVGESSLAVIGGVTILTEPSVFVEFSAQGGLAPDGRCKAFSDAADGTGWAEGVGVLVA
ERLSDAQRNGHPVLAVLRGSAVNQDGASNGLTAPNGPSQERVIQQALARTGLTPADIDAV
EAHGTGTRLGDPIEAQALLATYGQGHTPDQPLWLGSLKSNIGHTQAAAGVAGVIKMVMAL
RHGHLPPTLHADAPSSHVDWSAGSVRLLTEGQQWPETGRPRRAAVSSFGISGTNAHALLE
QAP

>KSmegalomycin megal_001_KS_002.seq Expect = 0.0    length= 425( 2030- 2455)
LSALELRNRLTTATGVRLATTTVFDHPDVRTLAGHLAAELGGGSGRERPGGEAPTVAPTD
EPIAIVGMACRLPGGVDSPEQLWELIVSGRDTASAAPGDRSWDPAELMVSDTTGTRTAFG
NFMPGAGEFDAAFFGISPREALAMDPQQRHALETTWEALENAGIRPESLRGTDTGVFVGM
SHQGYATGRPKPEDEVDGYLLTGNTASVASGRIAYVLGLEGPAITVDTACSSSLVALHVA
AGSLRSGDCGLAVAGGVSVMAGPEVFREFSRQGALAPDGRCKPFSDEADGFGLGEGSAFV
VLQRLSVAVREGRRVLGVVVGSAVNQDGASNGLAAPSGVAQQRVIRRAWGRAGVSGGDVG
VVEAHGTGTRLGDPVELGALLGTYGVGRGGVGPVVVGSVKANVGHVQAAAGVVGVIKVVL
GLGRGL

>KSmonensin monen_001_KS_002.seq Expect = e-140  length= 425( 1079- 1504)
DPVAIVAMSCRYPGGAGTPEDLWRLVADGADAIGDFPTDRGWDLARLFHPDPDRSGTSCT
RQGGFLYDAADFDAEFFDISPREALAVDPQQRLLLECAWEAFERAGLDPRALKGSPTGVF
VGMTGQDYGPRLHEPSQATDGYLLTGSTPSVASGRLSFSFGLEGPALTVDTACSSSLVTL
HLAAQALRRGECDLALAGGATVLATPGMFTEFSRQRGLAPDGRCKPFAAGADGTGWAEGV
GLVLLERLSEARRKGHAVLAVIRGSAINQDGASNGLTAPNGPSQQRVIRAALAAARLTAD
EVDVVEAHGTGTTLGDPIEAQALLATYGQGRSAERPLWLGSVKSNIGHTQAAAGVAGVIK
MVMAMRHDLLPATLHVDEPSGHVDWSTGAVRLLTEPVVWPRGERPRRAAVSSFGISGTNA
HLVLEE

>KSpimaricin pimar_002_KS_001.seq Expect = e-143  length= 427(   34-  461)
EPLAIVSMACRFPGGVRSPEELWELLRDGVDAVSSFPRNRGWDLDALYHSDPAHQGTSYA
REGGFLHDAGEFDPGFFGISPREALAMDPQQRLLLETAWEAVERAGIDPESLAGSRTGVF
VGTGHGGYDAEGRRRADEVGGHLLTGNHISIASGRISYVLGLEGPALTVDTACSSSLVAL
HLAMHALRRDECAMALVGGATVMSTPQMFVEFSRQRGLAPDGRCKPFAAAADGTGWSEGV
GLLLVERLSDAVRNGYPVLAVLKGSAVNQDGASNGLTAPNGPSQQRVIRQALTGAGLAAS
DIDAVEAHGTGTTLGDPVEAHALLATYGQQRAADRPCGLGSMKSNIGHTQAAAGIAGVMK
MVLAMRHGHLPRTLHLDEPTGHVDWSEGNARLLAEPEPWPSAGRPRRAAVSSFGISGTNA
HVILEQAP

>KSconcamycin conca_001_KS_002.seq Expect = e-145  length= 428( 1016- 1444)
EPVAVVGMACRLPGGVVSPAGLWELVAEGRDGVSGFPVDRGWDVEGLFDPDPDRPGTSYT
RHGGFLHDAAEFDAEFFGISPREALAMDPQQRLLLESSWEAVESAGIDPHALRGSRTGVF
AGTFTFRDSDNGVRLPDSSEGRRLTGGAASVLSGRVAFSLGLEGPAVTVDTACSSSLVAV
HLAVSALRAGECSLALAGGVTVMSSPGTFVEFSRQRGLSVDGRCRSFAASAGGTGWAEGV
GLLVLERLSDARRHGHRVLAVVRGSAVNQDGASNGLTAPSGRAQERVIRAALSSAGVTAA
EVDVVEAHGTGTRLGDPIEAQALLATYGRERPAERPLWLGSLKSNIGHAQAAAGVAGVIK
MVMALQRRALPRTLHVDEPTPLVDWASGGVELLTEQREWEAVEGRPRRAGVSSFGISGTN
AHLILEEAP

>KSmyxothiazol myxot_001_KS_002.seq Expect = e-116  length= 429( 2220- 2649)
EPIAVVGMACRLPGSVRSPEEFWRLLANGVNAVREVPKDRWSLDTWYDPDPETPGKMYSR
HGGFLDEVDPFDASFFGISAPEARSMDPQQRILLELGWEALESAGIAVDQLKGSPTGVFL
GICLSDYALLELNSPDPTGINAYSGSGGVLSVAAGRIAYALGLEGPTLAVDTACSSSLVA
AHLACQSLRNGECDLALVGGSNLLLSPRMSVYFSKLKALSPDGACKAFDSSANGYVRGEG
AGVLVLKRLSEALADGDPILSVMRGTAVNQDGRSNGLTAPSRAAQERVIESALRQGGVSP
LDVSYVEAHGTGTSLGDPIEVQALAAVLGKDRPRSAPLGIGSVKTNVGHLEGAAGVTSLI
KAILALRHRELPRSLHFKTPSPHIPWDELPVEVISEHRPWRVPEGKRRILGVSSFGFSGT
NAHVILEEAP

>eryth_001_KS_002.seq Expect = 0.0    length= 424( 1980- 2404)
EPIAIVGMACRLPGEVDSPERLWELITSGRDSAAEVPDDRGWVPDELMASDAAGTRAHGN
FMAGAGDFDAAFFGISPREALAMDPQQRQALETTWEALESAGIPPETLRGSDTGVFVGMS
HQGYATGRPRPEDGVDGYLLTGNTASVASGRIAYVLGLEGPALTVDTACSSSLVALHTAC
GSLRDGDCGLAVAGGVSVMAGPEVFTEFSRQGALSPDGRCKPFSDEADGFGLGEGSAFVV
LQRLSDARREGRRVLGVVAGSAVNQDGASNGLSAPSGVAQQRVIRRAWARAGITGADVAV
VEAHGTGTRLGDPVEASALLATYGKSRGSSGPVLLGSVKSNIGHAQAAAGVAGVIKVLLG
LERGVVPPMLCRGERSGLIDWSSGEIELADGVREWSPAADGVRRAGVSAFGVSGTNAHVI
IAEPP

*******************************************************************************

Trans-AT PKS
>KSmupirocin mupir_001_KS_002.seq Expect = 3e-90  length= 415( 1875- 2290)
QAIAIVGISGRFPQSRDLDAFWEHLAAGADLVSTVQRWDPRHCYAGADQGCDRGGFIERI
DEFDPLFFNISPLEATYMDPQQRLFLQEAWNALADAGCLGEQRRAEVSVYVGCEQGDYDQ
LFDDMPPPQSFWGNAPSIVPARIAYYLDLQGPAITVDTACSSALVAIHMACQSLLAGDTK
VALAGGVFIQSTPAFYQKANRASMLSLTGACHTFDSRADGFVPGEGAGAVVLKRLADALA
DRDHIHGLIRGSGINQDGASNGITAPSALSQQRLHESVYARYGIDPATVQLVEAHGTGTR
LGDPIEFQALKGAFSRYTQRKGYCAIGSVKSNMGHAATAAAMAGLFKVLLAMRHRQLPPS
LHFQHTNPAIDFADSPFFLNQHLGDWPAIDGAPRRAAISSFGFSGTNAHMVLEQPP

>rizox_002_KS_002.seq Expect = 2e-78  length= 441( 1755- 2196)
EPIAIIGLAGRFPGAADIDSFWNNLKNGVDSISEIPAERWEHSKYYSRDRSVKGKIHTKW
GGFIDDIDRFDPLFFNISPRDAERMDPQERIFLETAWRTLEDAGYDRAGLRRHYQGEMGV
FVGVMHGEYLLYTRSSAPDCTEDAVDSSFGSIANRVSYVFDCNGPSMAVDTICSSSLTAL
HLAVESLRRGECQLALAGGVNLSLHPNKYFIQSQLTMSSSDGRCRSFGDGGDGFVPGEGV
GAVLLKPLSRAEADGDNIYAVIRATSINHNGKTHGYTVPSPNAQGAMIADSLDKAGMDPR
ELSYIEAHGTGTALGDPIEITGLQLGFTRRSATLGSAMASAQQCAVGSVKSNIGHLESAA
GIAGIAKVLLQLKHRQLAPSLHSKRLNPNIPFADSPFYIPQQLQEWRRPVLNLDGREREY
PRAASVSSFGSGGSNGHVIIAE

********************************************************iterative typeI PKS

>KSavilamycin AVILA_001_KS_001.seq Expect = e-114  length= 435(   25-  460)
PVAVVGIGCRFPGGVNSPGEFWDLLTAGRNTVGEMPPDRWEEYRDFGPRFDAALRTAIRS
GSFLDDDIAGFDAEFFGISPREAELMDPQQRLMLEVAWQALEHAGIPPHTLAGTDTGVFA
GVCTYDYGAGRLEDLPNIDAWTGIGAAVCAVSNRVSHALDLRGPSLSIDTACSASLVALH
TAAQSLRLGECTVALAGGVNLLVSPGQTIALGTAGALAPDGRSKPFAASAGRYAVAASAD
GYGRGEGCGVLVIKLLTDAVRDGDRVLAVLRGSAFNQDGRTNGIMAPCGQAQEHVMRRAL
TAAGVAADTVDFVEAHGTGTRLGDPMEIGAIAAVYGRDRSGQEPCAVGSVKSNIGHLEGA
AGVAGVIKAILALDEDRIPASLLDGDPNPEIDWAGLDIRLATRALPWPERPHPRRAAVSG
FGYGGTVAHVVLEQAP

>KSC1027_001_KS_001.seq Expect = 4e-54  length= 455(    4-  459)
IAIVGVACTYPDATTPRELWENAVAGRRAFRRLPDVRMRLDDYWNPDPTVPDTFYARNAA
VLEGWEFDRVAHRIAGSTFRSTDLTHWLALDTATRALADAGFPAGEGLPTERTGVVVGNT
LTGEFSRANGLRLRWPYVRRILADALQEQEWDDDRLGAFLRGVEEAYKKPFPAVDEDTLA
GGLSNTIAGRICNHFDLNGGGYTVDGACSSSLLSITTAATSLQSGDLDVAVAGGVDLSID
PFEIIGFAKTGALARKEMRLYDRGSNGFWPGEGCGMVVLMREEDAVASGHRIYASIAGWG
ISSDGQGGITRPEVSGYQLALSRAYDRAGFGIETVPLFEGHGTGTAVGDATELRAIMSAR
AAADPHAPSAVITSIKGMIGHTKAAAGIAGLIKAVMALDSGVLPPAIGCVDPHDLLTDES
ANLRVLRKAESWPENAPLRAGITAMGFGGINTHVVL

>KSesperamicin esper_001_KS_001.seq Expect = 7e-58  length= 454(    6-  460)          
DAIAVVGLGCRHPDASTPEQLWETVLARRRAFRPLPRERLDLGDYGDPAAGPDATDLRYA
AVLDGWSFDRSRYRVPGPAYRVTDLAHWLALDVAGDTLAAAGFAGGGGLDRRRAGVILGN
TLTGEFSRAALMRLRWPYVRRNLVSALAARGWGAEEMGGLLREVEESYKEPFAEPNDESL
VGGLANAIAGRVCNHFDFRGAGYTVDGACSSSLLAVITACTYLRDGDLDFALAGGVDLSL
DPFELVGFSRLGALAGSAMRVYDARPTGFLPGEGCSMVALMRAGDAVAAGRRPIALIRGW
GMSSDGNGGLTRPDVSGQRLALERAYARAGFGPETVALFEGHGTGTEVGDRTELHALAEI
HDGRRRPRPAALGSVKANIGHTKAAAGAAGLIKAALALQRQVIPPTTGCDEPHPLLREPG
APLRVVREAEPWPDAPLRAGVSAMGFGGINTHVVL


**********************************************trans-AT pks
>KSdifficidin diffi_002_KS_002.seq Expect = 2e-74  length= 416( 2098- 2514)
IAVIGLSGRYPGADHVDELWENVKAGRHSITEVPKDRWDWKTFYNEERGKWGSIYSKWGG
FLEDIDKFDPLFFRISPAEAERMDPQERVFLQTAYSSIEDAGYTPATLCDSRKIGVFVGV
MNSNYPTVPSDWSIANRVSFLFNFQGPSMAVDTACSSSLTAVHLAAESLRSGMSETAIAG
GVNLIVDPAHYERLSAFSMLSPGEKCKSFGDSADGFVDGEGVGAIVLKPLAQAEKDGDHI
YGVIKGSMLNAAGRTNAYMVPNPKAQFDLIAETLKRTDIHPRTVSYLEAHGTGTALGDPI
EIDGLTKAFRLTTEDRQFCSIGSIKSNIGHLESAAGIAGITKLLLQLKHKRIAPSLHAAE
LNPNIEFEHTPFFVQQKETEWKRPVLNITGEMKEYPRIAGISSFGAGGSNAHVIIQE

>KSmupirocin mupir_001_KS_002.seq Expect = 3e-90  length= 415( 1875- 2290)
QAIAIVGISGRFPQSRDLDAFWEHLAAGADLVSTVQRWDPRHCYAGADQGCDRGGFIERI
DEFDPLFFNISPLEATYMDPQQRLFLQEAWNALADAGCLGEQRRAEVSVYVGCEQGDYDQ
LFDDMPPPQSFWGNAPSIVPARIAYYLDLQGPAITVDTACSSALVAIHMACQSLLAGDTK
VALAGGVFIQSTPAFYQKANRASMLSLTGACHTFDSRADGFVPGEGAGAVVLKRLADALA
DRDHIHGLIRGSGINQDGASNGITAPSALSQQRLHESVYARYGIDPATVQLVEAHGTGTR
LGDPIEFQALKGAFSRYTQRKGYCAIGSVKSNMGHAATAAAMAGLFKVLLAMRHRQLPPS
LHFQHTNPAIDFADSPFFLNQHLGDWPAIDGAPRRAAISSFGFSGTNAHMVLEQPP
*************************************************************************************
